Boundless Bio (BOLD) Income Statement: Revenue & Earnings

Boundless Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Boundless Bio, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00
Cost of Revenue	1.09	0.00	0.00	0.00
Gross Profit	-1.09	0.00	0.00	0.00
Operating Expenses
Research & Development	55.27	42.64	37.16	19.28
Selling, General & Administrative	18.00	12.16	9.31	6.02
Operating Expenses	72.18	54.80	46.47	25.30
Operating Income	-73.27	-54.80	-46.47	-25.30
Other Income/Expense
Interest Income	7.89	5.28	0.67	0.10
Interest Expense	0.00	0.00	0.00	0.00
Other Income/Expense	7.90	0.08	-0.10	0.00
Income
Income Before Tax	-65.36	-49.43	-45.90	-25.21
Income Tax Expense	0.00	0.00	0.00	0.00
Net Income	-65.36	-49.43	-45.90	-25.21
Net Income - Continuous Operations	-65.36	-49.43	-45.90	-25.21
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00
EBITDA	-64.28	-53.84	-45.53	-24.62
EBIT	-65.36	-54.80	-46.47	-25.30
Depreciation & Amortization	1.09	0.96	0.94	0.68
Earnings Per Share
Basic EPS	-4.00	-2.00	-42.00	-29.00
Diluted EPS	-4.00	-2.00	-42.00	-29.00
Basic Shares Outstanding	16.98	22.24	1.10	0.86
Diluted Shares Outstanding	16.98	22.24	1.10	0.86